Thornburg Investment Management’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-214,973
Closed -$13.6M 207
2022
Q1
$13.6M Sell
214,973
-2,901
-1% -$158K 0.18% 98
2021
Q4
$11.6M Sell
217,874
-27,269
-11% -$1.66M 0.14% 129
2021
Q3
$17.3M Sell
245,143
-1,432
-0.6% -$90.4K 0.21% 86
2021
Q2
$16.4M Buy
246,575
+76,422
+45% +$5.41M 0.19% 100
2021
Q1
$18.9M Sell
170,153
-113,994
-40% -$14.1M 0.22% 91
2020
Q4
$33.7M Buy
284,147
+71,355
+34% +$7.68M 0.4% 57
2020
Q3
$18.6M Buy
+212,792
New +$18.6M 0.25% 78

Other funds holding HAE

Thornburg Investment Management's HAE Position: Q2 2022 in Review

Thornburg Investment Management sold out of Haemonetics (HAE) in Q2 2022, closing a stake of 214,973 shares — an estimated $13.6M sold.

Thornburg Investment Management first reported a position in HAE in Q3 2020 and held it in 7 quarters. The position peaked at $33.7M in Q4 2020. 241 funds tracked by Wall St. Rank hold HAE as of Q2 2022.

  • Thornburg Investment Management reported no remaining Haemonetics position as of Q2 2022 after selling out during the quarter.
  • Thornburg Investment Management sold 214,973 Haemonetics shares in Q2 2022, an estimated $13.6M.
  • Thornburg Investment Management first reported a position in Haemonetics in Q3 2020 and held it in 7 quarters.
  • Thornburg Investment Management's Haemonetics position peaked at $33.7M in Q4 2020.
  • 241 funds tracked by Wall St. Rank held Haemonetics as of Q2 2022.

Based on Thornburg Investment Management's 13F filing for Q2 2022, filed 5 Aug 2022.